About admin

This author has not yet filled in any details.
So far admin has created 25 blog entries.

Test-and-treat strategy using Urea Breath Tests is cost-effective in managing symptoms and consequences from Helicobacter Pylori infection

Test-and-treat strategy using Urea Breath Tests is proven to be cost-effective in managing symptoms and consequences from Helicobacter pylori infection, thus contributing to preventing peptic ulcer and gastric cancer.

For more information regarding this subject please refer to our latest Press Releases.

Back to News

2020-01-14T18:09:49+02:00February 4th, 2019|

USING UREA BREATH TESTS IS PROVEN TO BE A COST-EFFECTIVE METHOD FOR MANAGING SYMPTOMS AND CONSEQUENCES OF HELICOBACTER PYLORI BACTERIA INFECTION

Almost 60% of the world population is infected with the Helicobacter pylori bacteria: a new study establishes that a test-and-treat strategy using Urea Breath Tests is cost-effective in managing symptoms and consequences from this infection, thus contributing to prevent peptic ulcer and gastric cancer.

Helicobacter pylori infection is a major public health issue affecting 60% of the world’s population with 90% of Peptic Ulcer attributed to and 80% of Gastric Cancers associated with Hp infection.

With the support of an international expert panel composed of Pr Javier Gisbert & Dr Adrian Mc Nicholl (Spain), Pr Francesco Franceschi (Italy), Pr Peter Malfertheiner (Germany) and methodologists, a new study has been carried out to assess different strategies for Helicobacter pylori infection diagnosis & eradication control.

The results have been presented by Dr Adrian McNicholl (Hospital Universitario de La Princesa, Madrid, Spain) at the XXXIst International Workshop on Helicobacter & Microbiota in Inflammation and Cancer in Kaunas (Lithuania) on 14th September 2018 during a “State of the Art” session.

The study shows that a “Test & Treat strategy” including the use of Urea Breath Tests as recommended in Spain is as effective as carrying out an endoscopy alone and has shown to be cheaper and more cost-effective than the symptomatic treatment strategy to manage dyspeptic patients. This strategy also seems to be the most cost-effective to prevent gastric cancer.

Pr Javier Gisbert, (Hospital Universitario de La Princesa, Madrid, Spain) stated: “although this Test & treat” strategy is incorporated in guidelines in multiple countries, the analysis of the European Hp registry covering more than 20‘000 patients shows that it is not always implemented. We need to teach our colleagues to align clinical practice with guidelines and the results from this cost-effectiveness study is an excellent opportunity for this”

Jean-Nicolas Vernin, President of Mayoly Spindler declared: “as a key player in the field of Helicobacter pylori infection management, Mayoly Spindler is very proud to support this project with the aim to improve the diagnostic and the management of patients with Hp infection and help preventing Peptic Ulcer and Gastric Cancer across the world”.

By increasing awareness from Health Authorities, insurers, physicians, pharmacists and patients on the need for early diagnosis and eradication of Hp infection, this study will contribute to develop efficient prevention programs against Peptic Ulcer and Gastric Cancer.

2020-01-16T12:10:42+02:00November 27th, 2018|

DMI presents the QALYs’ inadequacies during the Ethics Prize Seminar in Stockholm

Dr Ariel Beresniak took part in the Ethics Prize Seminar in Stockholm in October 2016, where he discussed once again how inadequate, inaccurate and unethical the QALY approach is when used for making a decision about new medicines’ access to patients in need. 

This seminar was organised by the Swedish Council of Medical Ethics.

The full seminar broadcast can be viewed here. Dr Ariel Beresniak’s presentation starts at 1:50:13.

More information on the QALYs and DMI’s role in the ECHOUTCOME project: www.echoutcome.eu.

Back to News

2020-01-14T18:09:49+02:00December 19th, 2016|

New publication related to the EHR4CR project on the re-use of the electronic health data

The European research project Electronic Health Records for Clinical Research (EHR4CR) was co-funded by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Innovative Medicines Initiative. A new budgetary impact assessment published in the Journal of Health & Medical Informatics reveals that compared to current practices, the EHR4CR platform appears cost-saving for pharmaceutical industry, the primary sponsor of clinical trials.

 

The full article is available here.

More information on the EHR4CR project: www.ehr4cr.eu.

Back to News

2020-01-14T18:09:49+02:00August 9th, 2016|

Public Health promoted by Classical Music – a concert-conference hosted by DMI in the frame of the ASSET project

It is a well-known fact how music positively affects the intellectual development and improves the concentration. This relationship, appreciated by musicians and music fans is gradually gaining more attention also from the scientific research teams around the world. The scientific consortium ASSET, financed by the European Commission, proposes a unique way of integrating classical music in the promotion of public health by organising a piano concert where the classical piano pieces will be accompanied by the presentations of six international scientific experts.

“Concerto for Piano and Sciences” is the first event of this kind organised together with the Verbier Festival (Switzerland), one of the most esteemed classical music festivals in Europe. Andrey Gugnin, a Russian virtuoso pianist and laureate of several prestigious international piano competitions will include Verbier in his world tour and will perform on the Bösendorfer grand piano 12 Études opus 25 by Frédéric Chopin as well as the sublime but rarely heard Sonata Romantica by Nicolaï Medtner.

Dr Ariel Beresniak, the CEO of the research organisation Data Mining International and the host of this concert-conference said: « We have a great pleasure and honour to organise this event in partnership with the Verbier Festival, creating a unique opportunity for the public to attend to the combination of the virtuoso classical piano music and extremely informative public health interventions proposed by international experts. It’s not often that both the right and the left hemispheres of the human brain can be stimulated in this fashion at the same time in order to better understand the role and the impact of music on the education and the disease prevention. »

The topics presented by the public health experts during the concert-conference will touch more particularly on the aspects of individual and collective health (Dr Ariel Beresniak), the music’s impact on the brain (Dr Pierre Lemarquis), the cognitive effects of the early music education (Hélène Vareille), the human epidemics of animal origin (Dr Donato Greco), the epidemics response strategies (Dr Sylvie Briand) as well as various defence mechanisms that the communities can employ against future pandemics (Dr Alberto Perra).

Concerto for Piano and Sciences

Saturday 30 July 2016 at 16:00

Espace St Marc, Verbier/Le Châble, Canton du Valais, Switzerland

Reservation online for free entrance:

https://fvf-autresmanifestations.shop.secutix.com/

Press contacts and group reservations: concert@datamining-international.com

Back to News

2020-01-14T18:09:49+02:00July 13th, 2016|

DMI will discuss the QALY approach and its risks during the next HTAi conference in Tokyo, Japan

Data Mining International will be participating in the symposium arranged by Pfizer during the next HTAi conference in Tokyo, in order to present the risks and inadequacies of the QALY approach used for resource allocations by several countries’ national health reimbursement systems. DMI will also discuss the scientifically more valid and robust alternatives to determine the cost-effectiveness of new medicines and technologies that can be confidently used in place of QALYs.

The information about the HTAi, 10-14 May 2016:

http://meeting.htai.org/events/tokyo2016/event-summary-4023afce0ec04ab387500e87f0a6a42d.aspx

Back to News

2020-01-14T18:09:50+02:00May 3rd, 2016|

A new article about the impact of hair colouring on Quality of Life is published in the Journal of Cosmetology and Trichology

“Assessing the hair colouring’s impact on Quality of Life” – the recently published article describes how the internationally validated BeautyQoL -instrument can be used to assess the cosmetic products’ impact on Quality of Life and more particularly talks about the original study where two hair colour products were compared and demonstrated to have a positive effect.

The full article can be accessed through this link:

http://www.omicsonline.org/open-access/assessing-the-hair-colourings-impact-on-quality-of-life-jctt-1000103.php?aid=66127

Back to News

2020-01-14T18:09:50+02:00May 3rd, 2016|

HAIR COLORING IMPROVES QUALITY OF LIFE

Hair coloring positively impacts Quality of Life, says a new scientific study. The role that the hair plays on both men and women’s identity has been evident throughout history, the hair – its style, color, abundance or luck thereof – representing often femininity, virility, freedom, beauty, as well as belonging to a specific religion and culture. While we all intuitively know about the link between our physical appearance and our well-being, very little research has been carried out in order to ascertain that relationship.

Some cosmetics companies work together with hospitals in order to speed up recovery of patients suffering of cancer in organizing cosmetic workshops inside the hospital. The successful results of these initiatives that often involve hairstyle variations point out not only to the impact on general well-being but indirectly also on general health.

The new measuring instrument, BeautyQoL has been specifically developed to scientifically assess the effect of cosmetic products on Quality of Life, leveraging the common fact that the way we look can indeed influence the way we feel, think and interact with others. The scientific article recently published in the Journal of Cosmetology and Trichology presents the results of this study assessing two popular haircoloring products from L’Oréal (Excellence® by L’Oréal Paris and Olia® by Garnier).

Tested on a total of 240 adult women whose age ranged from 45 to 70, BeautyQoL confirmed the improvement of quality of life both on the general index as well as dimension-specific scores, demonstrating the added value of the tested hair coloring products.

The importance of this new generation of studies using BeautyQoL is that it scientifically demonstrates how the cosmetic products – in this case hair color – don’t just enhance one’s physical appearance in a superficial way but actually impact one’s self-esteem, social relations and general well-being.

According to Dr Ariel Beresniak, project leader of the BeautyQoL initiative and Chief Executive Officer of Data Mining International, an independent research agency based in Geneva, Switzerland:

“For the very first time, these findings confirm the interest, sensitivity and robustness of the BeautyQoL instrument in assessing branded cosmetic products that relate to physical appearance”.

Indeed, considering the financial importance of the hair and beauty industry as well as the deep psychological and emotional relationship that women (and men) of all ages and all cultures have with their hair style, this innovative scientific approach shows the marketed hair coloring products and their impact in a completely new light, demonstrating how a seemingly simple action can have significant and far reaching positive consequences on people’s lives.

*Assessing the Hair Colourings’ Impact on Quality of Life. Beresniak et al., J Cosmo Trichol 2015, 1:1. http://dx.doi.org/10.4172/jctt.100010

Back to Press Releases

2020-01-16T13:36:25+02:00April 14th, 2016|

Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project

In the frame of the EHR4CR project*, a new article has been published in the Contemporary Clinical Trials on the Cost-Benefit Assessment of using EHR for clinical research when compared current practices. The full article can be downloaded for a limited time here: http://authors.elsevier.com/a/1S7v25WqQgX59b

Or from the home page of the journal: http://dx.doi.org/10.1016/j.cct.2015.11.011

* More on the IMI EHR4CR project : http://www.ehr4cr.eu

Back to News

2020-01-14T18:09:50+02:00December 3rd, 2015|